Blue Bell Private Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Blue Bell Private Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-150	Closed	-$20K	–	407
2016 Q3	$20K	Hold	150	–	–	0.01%	296
2016 Q2	$14K	Hold	150	–	–	0.01%	332
2016 Q1	$11K	Hold	150	–	–	0.01%	354
2015 Q4	$10K	Hold	150	–	–	0.01%	374
2015 Q3	$14K	Hold	150	–	–	0.01%	344
2015 Q2	$18K	Hold	150	–	–	0.01%	330
2015 Q1	$13K	Hold	150	–	–	0.01%	351
2014 Q4	$10K	Sell	150 -100	-40%	-$7.3K	0.01%	376
2014 Q3	$20K	Buy	+250	New	+$22.1K	0.01%	347

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Bell Private Wealth Management's GWPH Position: Q4 2016 in Review

Blue Bell Private Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 150 shares — an estimated $20K sold.

Blue Bell Private Wealth Management first reported a position in GWPH in Q3 2014 and held it in 9 quarters. The position peaked at $20K in Q3 2016. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

Blue Bell Private Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
Blue Bell Private Wealth Management sold 150 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $20K.
Blue Bell Private Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 9 quarters.
Blue Bell Private Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $20K in Q3 2016.
164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on Blue Bell Private Wealth Management's 13F filing for Q4 2016, filed 30 Jan 2017.